BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1825453)

  • 21. Renal response to vasopressin after inhibition of prostaglandin synthesis.
    Fejes-Tóth G; Magyar A; Walter J
    Am J Physiol; 1977 May; 232(5):F416-23. PubMed ID: 860762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of V2 antagonist on clearance of arginine vasopressin by isolated perfused rat kidneys.
    Keeler R; Sato AK; Claybaugh JR; Wilson N
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R665-9. PubMed ID: 1887953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of losartan, prazosin and a vasopressin V1-receptor antagonist on renal and femoral blood flow in conscious sheep.
    Ullman J; Eriksson S; Rundgren M
    Acta Physiol Scand; 2001 Jan; 171(1):99-104. PubMed ID: 11350268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs.
    Liard JF
    Am J Physiol; 1994 Jan; 266(1 Pt 2):H99-106. PubMed ID: 8304528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. V2-like receptors mediate cerebral blood flow increase following vasopressin administration in rats.
    Koźniewska E; Szczepańska-Sadowska E
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):579-85. PubMed ID: 1691387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of clonidine on the kidney function in the anesthetized dog.
    Kövér G; Tost H; Darvasi A
    Acta Physiol Hung; 1989; 74(3-4):229-41. PubMed ID: 2640405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects on renal sodium and potassium excretion of vasopressin and oxytocin in conscious dogs.
    Andersen SE; Engstrøm T; Bie P
    Acta Physiol Scand; 1992 Jul; 145(3):267-74. PubMed ID: 1519485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential sensitisation to central cardiovascular effects of angiotensin II in rats with a myocardial infarct: relevance to stress and interaction with vasopressin.
    Cudnoch-Jedrzejewska A; Szczepanska-Sadowska E; Dobruch J; Puchalska L; Ufnal M; Kowalewski S; Wsół A
    Stress; 2008 Jul; 11(4):290-301. PubMed ID: 18574789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and therapeutic utility of vasopressin antagonists in rats.
    Kinter LB; Dytko G; Ashton D; McDonald J; Huffman W; Stassen F
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S36-43. PubMed ID: 2434770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion.
    Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Ohta M; Yoshinaga K
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E856-62. PubMed ID: 1535483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins.
    Kompanowska-Jezierska E; Emmeluth C; Grove L; Christensen P; Sadowski J; Bie P
    Am J Physiol; 1998 Jun; 274(6):R1619-25. PubMed ID: 9608016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of renal medullary blood flow by vasopressin V1 and V2 receptors.
    Nakanishi K; Mattson DL; Gross V; Roman RJ; Cowley AW
    Am J Physiol; 1995 Jul; 269(1 Pt 2):R193-200. PubMed ID: 7631893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of vasopressin V (OPC-21268) and V2 (OPC-31260) antagonists on renal hemodynamics and excretory function.
    Nakamura T; Sakamaki T; Kurashina T; Hoshino J; Sato K; Ono Z; Murata K
    Life Sci; 1994; 55(4):PL67-72. PubMed ID: 8028441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of effect of prostaglandin E 1 on renal water excretion.
    Berl T; Schrier RW
    J Clin Invest; 1973 Feb; 52(2):463-71. PubMed ID: 4683884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of receptor blockade on metabolism and renal actions of vasopressin in conscious dogs.
    Grove L; Christensen P; Bie P
    Acta Physiol Scand; 1998 May; 163(1):93-101. PubMed ID: 9648627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge.
    Chagnon F; Vaidya VS; Plante GE; Bonventre JV; Bernard A; Guindi C; Lesur O
    Crit Care Med; 2008 Nov; 36(11):3054-61. PubMed ID: 18824919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular depression and stabilization by central vasopressin in rats.
    Imai Y; Abe K; Sasaki S; Minami N; Munakata M; Sakuma H; Hashimoto J; Nobunaga T; Sekino H; Yoshinaga K
    Hypertension; 1990 Mar; 15(3):291-300. PubMed ID: 2303287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin: a regulator of adrenal glucocorticoid production?
    Brooks VL; Blakemore LJ
    Am J Physiol; 1989 Apr; 256(4 Pt 1):E566-72. PubMed ID: 2539736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of the effects of vasopressin on plasma levels of free fatty acids and triglycerides in pygmy goats.
    Rossi R; Scharrer E
    Comp Biochem Physiol Comp Physiol; 1993 Feb; 104(2):287-90. PubMed ID: 8095881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.